Domů › Melanom › Pennsylvania › Philadelphia
Klinické studie Melanom v Philadelphia, PA
23 studií pro Melanom hledá účastníky v lokalitách v Philadelphia a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · Vzdálenost 22 mi
DESTINY-PANTUMOUR04
Probíhá náborObservační studie
- Research Site, Philadelphia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Probíhá náborFáze 2
- Thomas Jefferson University Hospital, Philadelphia
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Probíhá náborFáze 3
- Fox Chase Cancer Center, Philadelphia
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Probíhá náborFáze 2
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · Vzdálenost 25 mi
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Probíhá náborFáze 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · Vzdálenost 13 mi
- a dalších 3
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Probíhá náborFáze 1/2
- University of Pennsylvania, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Probíhá náborObservační studie
- University of Pennsylvania, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Probíhá náborFáze 1/2
- Children's Hospital of Philadelphia, Philadelphia
Project: Every Child for Younger Patients With Cancer
Probíhá náborObservační studie
- Drexel University School of Medicine, Philadelphia
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- a dalších 1
Tebentafusp-tebn With LDT in Metastatic UM
Probíhá náborFáze 1/2
- Thomas Jefferson University, Philadelphia
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Probíhá náborFáze 1/2
- Fox Chase Cancer Center, Philadelphia
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Probíhá náborFáze 1/2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Probíhá náborRaná fáze 1
- Fox Chase Cancer Center, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Probíhá náborFáze 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Probíhá náborFáze 3
- Jefferson Health Honickman Center, Philadelphia
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Probíhá náborFáze 2/3
- UPenn, Philadelphia
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Probíhá náborFáze 2/3
- Thomas Jefferson University, Philadelphia
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Probíhá náborFáze 3
- Thomas Jefferson University Medical Oncology Clinic, Philadelphia
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Probíhá náborFáze 3
- Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Philadelphia
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Probíhá nábor
- University of Pennsylvania, Philadelphia
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Probíhá nábor
- Fox Chase Cancer Center, Philadelphia
Studie Melanom v jiných městech
- Houston, TX59 studií
- New York City, NY38 studií
- Los Angeles, CA34 studií
- Nashville, TN33 studií
- Pittsburgh, PA31 studií
- Boston, MA26 studií
- San Francisco, CA22 studií
- Atlanta, GA21 studií
- Durham, NC21 studií
- St. Louis, MO21 studií
- Columbus, OH21 studií
- Salt Lake City, UT21 studií
Další studie v Philadelphia
- Rakovina (všechny typy)59 studií
- Rakovina prsu56 studií
- Nemalobuněčný plicní karcinom51 studií
- Metastatický karcinom46 studií
- Kolorektální karcinom44 studií
- Rakovina vaječníků44 studií
- Rakovina prostaty44 studií
- Rakovina plic36 studií
- Akutní myeloidní leukemie34 studií
- Srdeční selhání31 studií
- Rakovina endometria28 studií
- Deprese26 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.